by The BioPharma Team | Mar 17, 2022 | Clinical Research - All Blogs, Human Abuse Potential, Sponsors
How the end-to-end approach of a full-service clinical research organization (CRO) addresses human clinical trial challenges Drug discovery and development are crucial to introducing novel therapeutics in clinical practice, and the research in these fields is...
by The BioPharma Team | Mar 7, 2022 | Clinical Research - All Blogs, Human Abuse Potential, Sponsors
BioPharma Offers Renowned Human Abuse Potential (HAP) Studies and Abuse Deterrent Expertise Human abuse potential (HAP) studies, also known as human abuse liability testing, have gained relevance as the FDA becomes increasingly interested in knowing whether or not new...
Recent Comments